NBTX
Income statement / Annual
Last year (2023), Nanobiotix S.A.'s total revenue was $36.21 M,
an increase of 658.12% from the previous year.
In 2023, Nanobiotix S.A.'s net income was -$39.70 M.
See Nanobiotix S.A.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$36.21 M |
$4.78 M |
$10,000.00 |
$50,000.00 |
$68,000.00 |
$116,000.00 |
$251,968.00 |
$1.56 M |
$265,543.00 |
$967,500.00 |
| Cost of Revenue |
$0.00
|
$985,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$345,591.00
|
$436,307.00
|
$359,611.00
|
$0.00
|
| Gross Profit |
$36.21 M
|
$3.79 M
|
$10,000.00
|
$50,000.00
|
$68,000.00
|
$116,000.00
|
-$93,623.00
|
$1.12 M
|
-$94,068.00
|
$967,500.00
|
| Gross Profit Ratio |
1
|
0.79
|
1
|
1
|
1
|
1
|
-0.37
|
0.72
|
-0.35
|
1
|
| Research and Development Expenses |
$38.40 M
|
$32.64 M
|
$30.38 M
|
$24.33 M
|
$30.41 M
|
$20.89 M
|
$16.34 M
|
$16.92 M
|
$13.90 M
|
$8.08 M
|
| General & Administrative Expenses |
$21.66 M
|
$17.48 M
|
$19.43 M
|
$14.27 M
|
$18.64 M
|
$12.62 M
|
$12.34 M
|
$10.26 M
|
$7.19 M
|
$4.30 M
|
| Selling & Marketing Expenses |
$388,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.05 M
|
$17.48 M
|
$19.43 M
|
$14.27 M
|
$18.64 M
|
$12.62 M
|
$12.34 M
|
$10.26 M
|
$7.19 M
|
$4.30 M
|
| Other Expenses |
$2.54 M
|
-$3.41 M
|
-$2.64 M
|
-$2.07 M
|
-$2.20 M
|
-$3.33 M
|
-$337,890.00
|
$160,230.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$62.99 M
|
$46.70 M
|
$47.18 M
|
$36.53 M
|
$46.85 M
|
$30.18 M
|
$25.52 M
|
$23.41 M
|
$17.41 M
|
$10.59 M
|
| Cost And Expenses |
$62.99 M
|
$46.70 M
|
$47.18 M
|
$36.53 M
|
$46.85 M
|
$30.18 M
|
$25.52 M
|
$23.41 M
|
$17.41 M
|
$10.59 M
|
| Interest Income |
$1.22 M
|
$256,000.00
|
$6.17 M
|
$4.68 M
|
$105,000.00
|
$34,000.00
|
$33,026.00
|
$59,492.00
|
$183,218.00
|
$196,648.00
|
| Interest Expense |
$7.98 M
|
$5.84 M
|
$590,000.00
|
$333,000.00
|
$4.79 M
|
$847,000.00
|
$108,367.00
|
$102,203.00
|
$59,517.00
|
$55,726.00
|
| Depreciation & Amortization |
$551,000.00
|
$1.50 M
|
$1.56 M
|
$1.76 M
|
$1.77 M
|
$569,000.00
|
$345,591.00
|
$436,307.00
|
$456,080.00
|
$307,560.00
|
| EBITDA |
-$23.69 M |
-$45.15 M |
-$45.61 M |
-$31.49 M |
-$44.78 M |
-$29.33 M |
-$25.55 M |
-$21.21 M |
-$16.49 M |
-$9.11 M |
| EBITDA Ratio |
-0.65
|
-10.85
|
-4099.5
|
-599.06
|
-658.46
|
-252.83
|
-101.72
|
-13.61
|
-62.09
|
-9.42
|
| Operating Income Ratio |
-0.74
|
-9.78
|
-5257.9
|
-728.56
|
-687.93
|
-259.2
|
-100.28
|
-14.03
|
-64.55
|
-9.94
|
| Total Other Income/Expenses Net |
-$12.80 M
|
-$10.33 M
|
$5.58 M
|
$2.85 M
|
-$4.13 M
|
-$278,000.00
|
-$876,000.00
|
$64,607.00
|
$138,563.00
|
$142,523.00
|
| Income Before Tax |
-$39.58 M
|
-$57.03 M
|
-$47.00 M
|
-$33.61 M
|
-$50.91 M
|
-$30.35 M
|
-$26.14 M
|
-$21.79 M
|
-$17.00 M
|
-$9.48 M
|
| Income Before Tax Ratio |
-1.09
|
-11.94
|
-4699.9
|
-672.28
|
-748.71
|
-261.59
|
-103.76
|
-13.99
|
-64.03
|
-9.8
|
| Income Tax Expense |
$120,000.00
|
$10,000.00
|
$5,000.00
|
$9,000.00
|
$3,000.00
|
-$449,000.00
|
$20.00
|
$90,425.00
|
$37,578.00
|
$79,271.00
|
| Net Income |
-$39.70 M
|
-$57.04 M
|
-$47.00 M
|
-$33.62 M
|
-$50.92 M
|
-$29.90 M
|
-$26.14 M
|
-$21.88 M
|
-$17.00 M
|
-$9.56 M
|
| Net Income Ratio |
-1.1
|
-11.94
|
-4700.4
|
-672.46
|
-748.75
|
-257.72
|
-103.76
|
-14.04
|
-64.03
|
-9.88
|
| EPS |
-1.08 |
-1.64 |
-1.35 |
-1.38 |
-2.35 |
-1.52 |
-1.5 |
-1.43 |
-1.2 |
-0.74 |
| EPS Diluted |
-1.08 |
-1.64 |
-1.35 |
-1.38 |
-2.35 |
-1.52 |
-1.5 |
-1.43 |
-1.2 |
-0.74 |
| Weighted Average Shares Out |
$36.76 M
|
$34.85 M
|
$34.73 M
|
$24.39 M
|
$21.63 M
|
$19.62 M
|
$17.43 M
|
$15.28 M
|
$14.14 M
|
$12.87 M
|
| Weighted Average Shares Out Diluted |
$36.93 M
|
$34.85 M
|
$34.73 M
|
$24.39 M
|
$21.63 M
|
$19.63 M
|
$17.48 M
|
$15.28 M
|
$14.14 M
|
$12.87 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
